For IPO Boutique's "scale of 1 to 5" BUY rating on ContraFect Corporation, and our comprehensive analysis, click "Buy Market Research".
About ContraFect Corporation (adapted from ContraFect Corporation prospectus): They are a biotechnology company focused on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings.
This description is adapted from ContraFect Corporation prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as ContraFect Corporation "CFRXU" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
Used our Comprehensive Single Promo Advisory and want more?
